Core B Cellular Core
Core B Cellular Core
批准号:
9763628
负责人:
Andres Finzi
金额:
$10.02万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AntibodiesAntigensCCR5 geneCD4 AntigensCXCR4 geneCell surfaceCellsCellular MembraneClinicalComplexCyclic PeptidesEpitopesGlycoproteinsGoalsGrantHIVHIV Envelope Protein gp120Immune responseLaboratoriesMediatingMolecular ConformationMothsPatientsResistanceSamplingStructureSurfaceUrsidae FamilyViralVirusantibody-dependent cell cytotoxicitybasegp160inhibitor/antagonistinnovationmimeticspeptidomimeticsprogramsresponsesingle-molecule FRETsmall moleculevirologyvirus envelope
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Core B Project Summary:
The Goal of the Cellular Core (Core B) is to provide innovation and support to this Program Project to investigate
HIV-1 Env antagonism in the context of the conformational states sampled by native HIV-1 Env. Core B will
evaluate the impact of the small-molecule antagonists on sensitizing HIV-1-infected cells to antibody-dependent
cellular cytotoxicity (ADCC). Core B will also help delineate the mechanisms of action of small-molecule Env
inhibitors on trimeric Env expressed at the cell surface. Specifically, Core B will: (a) evaluate the ability of small-
molecule Env entry inhibitors for their ability to sensitize HIV-1-infected cells to ADCC and (b) assess their impact
on the conformation of functional Env trimers expressed on cell surfaces. Despite not being officially part of the
Program Project in the most recent grant period, the Finzi laboratory has been a long-term collaborator and
successfully interacted with Virology (Sodroski), Cyclic Peptides and Peptidomimetics (Chaiken), Small Molecule
Synthesis (Smith), and Single Molecule FRET (Mothes) Projects to advance the understanding of Env
conformational changes at the surface of infected cells, understand how Env conformations are modulated by
different small-molecule antagonists generated by the Program Project and assess their impact on Env
recognition and ADCC responses mediated by anti-Env antibodies and HIV+ sera.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A new strategy to eliminate HIV-1-infected cells by unlocking the Env trimer
-
批准号:10756846
-
项目类别:
-
资助金额:$71.63万
-
财政年份:2023
-
负责人:Andres Finzi
-
依托单位:
Characterizing HIV-1 Env conformations susceptible to attack by non-neutralizing antibodies
-
批准号:9925626
-
项目类别:
-
资助金额:$58.8万
-
财政年份:2019
-
负责人:Andres Finzi
-
依托单位:
Characterizing HIV-1 Env conformations susceptible to attack by non-neutralizing antibodies
-
批准号:10299622
-
项目类别:
-
资助金额:$54.06万
-
财政年份:2019
-
负责人:Andres Finzi
-
依托单位:
Characterizing HIV-1 Env conformations susceptible to attack by non-neutralizing antibodies
-
批准号:10517513
-
项目类别:
-
资助金额:$53.85万
-
财政年份:2019
-
负责人:Andres Finzi
-
依托单位:
Unlocking Env: A New Strategy for a Functional Cure Through Antibody-Dependent Cell-Mediated Cytotoxicity
-
批准号:9273185
-
项目类别:
-
资助金额:$49.85万
-
财政年份:2017
-
负责人:Andres Finzi
-
依托单位:
Core B Cellular Core
-
批准号:10240539
-
项目类别:
-
资助金额:$9.96万
-
财政年份:1997
-
负责人:Andres Finzi
-
依托单位:
Core B Cellular Core
-
批准号:10471371
-
项目类别:
-
资助金额:$9.94万
-
财政年份:1997
-
负责人:Andres Finzi
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: